We’re glad to announce our participation at CPhI Frankfurt 2025! We’re excited to join CPhI Worldwide once again, the leading event for the pharmaceutical industry. Meet us in Hall 12.1 – Booth D7 to explore new business opportunities, discuss innovative projects, and discover how we can support your API development needs. Whether you’re looking for a strategic...
We are excited to announce that Chemelectiva S.r.l. will be attending CPHI Japan from April 9th to 11th in Tokyo! Meet our CEO Graziano Castaldi and Business Development Gerardo Concilio, PhD at booth #4W43 to dicuss our expertise in developing innovative chemical processes for APIs and pharmaceutical intermediates. Feel free to contact us to schedule...
🌟 Chemelectiva S.r.l. is excited to announce its presence in DCAT Week 2025 in New York! 🌟 As a company dedicated to developing innovative and efficient processes for the synthesis of API, this event represents a valuable opportunity to connect with partners, and explore possible new collaborations. 📍 Where? Suite #1604 at San Carlos Hotel...
🌟 Merry Christmas & Happy New Year from Chemelectiva S.r.l. 🌟 As we step into the new year, we would like to extend our heartfelt wishes for a successful and fulfilling 2025 to our partners, customers, and colleagues. Thank you for being part of our journey! Here’s to a 2025 full of opportunities, growth, and...
Chemelectiva will participate in CpHI Japan 2024. CPhI Japan will be held from 17 to 19 April at Tokyo Big Sight Japan. CPhI Japan is Japan’s largest and most comprehensive pharmaceutical event; represents an important opportunity to come into contact with a large number of exhibitors operating in the various pharmaceutical fields and participate in...
Also this year our CEO, Graziano Castaldi, will be at DCAT Week in New York. DCAT Week is the premier event held annually in New York City for companies engaged in the Global Bio/Pharmaceutical Manufacturing Value Chain. It is hosted by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit, member-supported, global business development...
CHEMELECTIVA’s Team wishes you all the best for a happy Holiday Season and a Happy New Year! 2024 promises to be a year full of commitments and news for Chemelectiva. As previously announced, with the new year, the works started in March 2023 for the construction of the new cGMP manufacturing plant will be completed....
In the current month, our CEO Graziano Castaldi attended ChemOutsourcing, the largest trade show dedicated to APIs and Pharmaceutical Ingredients based in the United States. The sixteenth edition, which took place September 6-8, 2023 at the Parsippany Hilton in Parsippany, NJ, was again attended this year by many representatives of the chemical and pharmaceutical industry,...
Clascoterone is an androgen receptor inhibitor developed as a cream and solution for the treatment of androgen-dependent skin disorders, including androgenetic alopecia and acne vulgaris. In August 2020, 1% clascoterone cream received its first approval in the United States for the topical treatment of acne vulgaris in patients 12 years of age and older. Clinical...
© 2023 CHEMELECTIVA S.r.l. – R.E.A. Novara-0219053 Fiscal Code and VAT IT No.: 02157590031; Share Capital: € 300.000 fully paid up
Realizzazione: MayBee Comunicazione
